Medartis Holding AG header image

Medartis Holding AG

MED

Equity

ISIN CH0386200239 / Valor 38620023

SIX Swiss Exchange (2026-11-04)
CHF 110.60+3.75%

Medartis Holding AG
UMushroom community rating:

star star star star star
5.00 1 votes No rating yet
NegativeNeutralPositive

About company

Medartis Holding AG is a Swiss medical‑device company that develops, manufactures and sells internal fixation implants, instruments and surgical systems for orthopaedic and trauma applications, with particular emphasis on fixation of small and medium bones such as those of the hand, wrist, foot/ankle and cranio‑maxillofacial areas. Its product range includes titanium and stainless‑steel plates, screws, locking systems and complementary surgical instruments, which it supplies to hospitals and surgeons through a network of subsidiaries and distributors across multiple regions; the business model is driven by product sales, aftermarket instrumentation and incremental R&D and regulatory work to broaden its clinical portfolio. As a publicly listed specialist in the orthopaedic-trauma segment, Medartis competes on product engineering, clinical support and targeted market coverage rather than on broad hospital consumable lines.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

41.8%1Y
44.2%3Y
-14.1%5Y

Performance

35.6%1Y
38.9%3Y
42.5%5Y

Volatility

Market cap

1685 M

Market cap (USD)

Daily traded volume (Shares)

34,087

Daily traded volume (Shares)

1 day high/low

59.6 / 51.2

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

5.00

1 votes
Performance:
starstarstarstarstar
5.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Peter Jürg Burkard
Switzerland, 26 Mar 2025
star star star star star
Scheint gut zu laufen.

EQUITIES OF THE SAME SECTOR

Wockhardt Limited
Wockhardt Limited Wockhardt Limited Valor: 1848172
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.68%INR 1,899.80
Ajanta Pharma Limited
Ajanta Pharma Limited Ajanta Pharma Limited Valor: 27480449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.13%INR 3,313.55
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited Apollo Hospitals Enterprise Limited Valor: 11650098
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.58%INR 8,577.00
NATCO Pharma Limited
NATCO Pharma Limited NATCO Pharma Limited Valor: 30461955
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.01%INR 789.60
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.34%INR 582.05
Zydus Lifesciences Limited
Zydus Lifesciences Limited Zydus Lifesciences Limited Valor: 29835501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.95%INR 1,190.00
Dr. Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories Ltd. Dr. Reddy's Laboratories Ltd. Valor: 138953781
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.15%INR 1,372.00
IPCA Laboratories Limited
IPCA Laboratories Limited IPCA Laboratories Limited Valor: 115718957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.27%INR 1,973.15
Jubilant Pharmova Limited
Jubilant Pharmova Limited Jubilant Pharmova Limited Valor: 2477953
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.10%INR 939.45
Trupanion Inc
Trupanion Inc Trupanion Inc Valor: 24738737
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
8.21%USD 33.67